Crescita Therapeutics Inc
TSX:CTX
Crescita Therapeutics Inc
TSX:CTX
Price:
0.5
CAD
-3.85%
Market Closed
Market Cap:
CA$9.3m
Relative Value
The Relative Value of one
CTX
stock under the Base Case scenario is
hidden
CAD.
Compared to the current market price of 0.5 CAD,
Crescita Therapeutics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CTX Relative Value
HIDDEN
Multiples Across Competitors
CTX Competitors Multiples
Crescita Therapeutics Inc Competitors
Crescita Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Crescita Therapeutics Inc
TSX:CTX
|
9.3m CAD | 0.4 | 20.4 | 1.8 | -1.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
992.9B USD | 15.2 | 48.1 | 32.4 | 34.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.5B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.2B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.7B GBP | 5.1 | 31.7 | 15.1 | 22.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.1B USD | 4.5 | 16 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.6 | 13.8 | 10.1 | 11.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.9B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.2B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
